no statement of use filed
on 14 Sep 2020
Last Applicant/ Owned by
700 ELLICOTT STREET
BUFFALO
NY
14203
Serial Number
87172927 filed on 15th Sep 2016
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
"IMMUNE"
The mark consists of the word "OMNISEQ" over the phrase "IMMUNE ADVANCE"; with the letter "O" in "OMNISEQ" having a solid circle inside of the letter "O" with a line extending to the lower right and ending with a semi-circle; and with the letter "S" in "OMNISEQ" formed by two interlocking curved lines. OMNI SEQ IMMUNE ADVANCE Color is not claimed as a feature of the mark. providing molecular geRead More
providing molecular genetics and genomics testing and reporting services in the field of biomarkers for the susceptibility, risk, diagnosis, prognosis, treatment or management of cancer and other diseases
No 87172927
No Service Mark
No 2005T012
No
No
No
No
No
No
No
No
26.01.03 -
Incomplete circles (more than semi-circles)
26.01.06 -
Semi-circles
26.01.21 -
Circles that are totally or partially shaded
26.17.01 -
Straight line(s), band(s) or bar(s)
26.17.06 -
Diagonal line(s), band(s) or bar(s)
26.17.09 -
Curved line(s), band(s) or bar(s)
The mark consists of the word "OMNISEQ" over the phrase "IMMUNE ADVANCE"; with the letter "O" in "OMNISEQ" having a solid circle inside of the letter "O" with a line extending to the lower right and ending with a semi-circle; and with the letter "S" in "OMNISEQ" formed by two interlocking curved lines.
| Status Date | Action Taken |
|---|---|
| 14th Sep 2020 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 14th Sep 2020 | ABANDONMENT - NO USE STATEMENT FILED |
| 16th Jan 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 15th Jan 2020 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 15th Jan 2020 | EXTENSION 5 GRANTED |
| 10th Jan 2020 | EXTENSION 5 FILED |
| 10th Jan 2020 | TEAS EXTENSION RECEIVED |
| 08th Jul 2019 | ASSIGNED TO EXAMINER |
| 18th May 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 16th May 2019 | EXTENSION 4 GRANTED |
